| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |